GlassScriptPhysician profile
Taylor B Turner
NPI 1700176567
$34,080.49
in general payments reported to CMS, 2019-2025
14 companies · $5,954 in 2025
The $5,954 reported for 2025 was more than what 88% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $80.56 · 2021: $3,640 · 2022: $7,467 · 2023: $5,861 · 2024: $11K · 2025: $5,954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Consulting Fee: $3,953 · Food and Beverage: $2,782 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Travel and Lodging: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,766.91 |
| Consulting Fee | $3,952.50 |
| Food and Beverage | $2,782.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Travel and Lodging | $437.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,429.49 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Astrazeneca Pharmaceuticals LP | $4,408.40 | 2022-2025 | Lynparza, Enhertu, Imfinzi |
| Conmed Corporation | $2,154.18 | 2022-2024 | Airseal |
| Myriad Genetic Laboratories, INC. | $716.80 | 2022-2024 | Myrisk, Precisetumor |
| Glaxosmithkline, LLC. | $484.06 | 2020-2025 | Jemperli |
| Tesaro, INC. | $229.05 | 2019 | |
| Seagen INC. | $137.21 | 2022-2023 | Tivdak |
| Pfizer INC. | $130.23 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $99.95 | 2024-2025 | Lynparza |
| Therapeuticsmd, INC. | $91.10 | 2019 | |
| Tempus Ai, INC | $75.00 | 2025 | Xt Cdx |
| Foundation Medicine, INC. | $68.45 | 2019 | |
| Medtronic, INC. | $28.74 | 2025 | Signia |
| Ethicon US, LLC | $27.83 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.